Kimuli NamyaloAngella
ID: UNCST-2025-R022072
|
PREVALENCE OF HELICOBACTER PYLORI, ASSOCIATED FACTORS AND MAGNITUDE OF RESISTANCE AGAINST FIRST LINE ANTIBIOTICS AMONG CHILDREN PRESENTING WITH GASTRO-INTESTINAL SYMPTOMS AT HOLY INNOCENTS CHILDREN’S HOSPITAL, SOUTHWESTERN UGANDA
REFNo: HS6980ES
1. To determine the prevalence of H. pylori infection among children aged 1-16 years at Holy Innocents Children’s Hospital, southwestern Uganda
2. To assess the factors associated with the presence of H. pylori among children presenting with gastrointestinal symptoms at Holy Innocents Children’s Hospital, Southwestern Uganda
3. To determine the proportion of H. pylori strains that possess resistance genes to Amoxicillin, metronidazole and clarithromycin among the children population at Holy Innocents Children’s Hospital, Southwestern Uganda
|
Uganda |
2026-04-10 18:12:39 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Degree Award |
|
ASIPHAS OWARAGANISE
ID: UNCST-2026-R023544
|
Licensing Foreign Trained Doctors and Dentists in Uganda: Performance and Stakeholder Perspectives, 2015-2025.
REFNo: HS7299ES
Our overarching goal is to generate robust, mixed-methods evidence detailing trends, grades, and the perspectives of FTDs and their examiners to inform the professional council’s policies on licensure and workforce integration. Specifically, we will i) characterize the structural attributes and outcome performance of FTDs seeking licensure in Uganda, and ii) explore stakeholder experiences and perceptions of the medical licensure process for FTDs, situating findings within the context of evolving regional health workforce policies
|
Uganda |
2026-04-10 18:11:34 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Sally Hargreaves
ID: UNCST-2025-R022294
|
Designing for Immunization: A Co-design Thinking Approach to
Improving Catch-up Vaccination among South Sudanese Refugees in Uganda (TUKU-VAC Study)
REFNo: HS7289ES
This project aims to explore the drivers of catch-up vaccination uptake among South Sudanese refugees in Uganda and to co-design community-led solutions using a participatory, design thinking research approach. Refugees often face significant challenges in accessing vaccinations, including limited healthcare access, vaccine hesitancy, misinformation, and systemic barriers. This study seeks to gain a deeper understanding of these issues and develop culturally appropriate, sustainable strategies to improve uptake of essential catch-up vaccines. The study will utilise an adapted version of the World Health Organization’s Behavioural and Social Drivers (BeSD) of vaccination framework to examine the key social behavioural factors influencing vaccine uptake among migrants and refugees’ population. This framework considers four key domains: individuals’ cognitive and emotional responses to vaccine-preventable diseases and vaccines, the influence of social norms and recommendations, the level of motivation and willingness to be vaccinated, and the practical barriers individuals encounter when attempting to access vaccination services. In parallel, a complementary healthcare provider survey adapted from a CDC-developed knowledge, attitudes, and practices (KAP) survey on catch-up vaccination, previously implemented in a national study in the United States will be used to assess the knowledge, practices, and system-level barriers affecting the delivery of catch-up vaccination services to refugees. This tool covers four core domains: demographic and professional characteristics; knowledge and awareness of catch-up vaccination; service delivery practices; and perceived enablers and barriers to vaccine provision. The research will be conducted in collaboration with refugee communities and healthcare providers to ensure that interventions are locally relevant, practical, and effective. Through qualitative interviews and participatory co-design workshops, refugees and healthcare providers will collectively identify challenges and develop solutions that align with their needs and lived experiences.
|
UK |
2026-04-10 18:09:36 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
Richard Idro
ID: UNCST-2021-R013599
|
Dihydroartemisinin-piperaquine for the post-discharge management of children with severe acute malnutrition in Malawi and Uganda; A multicentre, parallel-group, two-arm, randomised, double-blind superiority trial [Short Title: Post-discharge Malaria Chemoprevention - SAM (PDMC-SAM)]
REFNo: HS7291ES
To determine if 4 months of PDMC with dihydroartemisinin piperaquine (DP) compared to placebo is superior in reducing hospital readmissions and death by 6 months in children aged <5 years admitted with ‘SAM’ who are clinically stable and ready to be discharged to OTC.,
|
Uganda |
2026-04-10 18:06:21 |
2029-04-10 |
Medical and Health Sciences |
Clinical Trial |
Non-degree Award |
|
alfred andama andama
ID: UNCST-2022-R011051
|
Evaluation of a novel molecular platform for MTB detection using contrived oral swab samples
REFNo: HS6821ES
To compare the performance of the BLINK X shaker with the reference lysis method,To optimize the lysis protocol for MTB detection from contrived oral samples using the BLINK X Shaker,To estimate the analytical sensitivity of the BLINK dPCR laboratory detection platform for MTB detection using contrived oral swab samples.,
|
Uganda |
2026-04-10 18:02:52 |
2029-04-10 |
Medical and Health Sciences |
Non-Clinical Trial |
Non-degree Award |
|
| View |
|
Sort By: |
|
|
|
| |
|